ストックスクリーナーアプリを入手
3.46
0.00%
0.00
Gossamer Bio Inc (GOSS) 最新ニュース
Gossamer Bio (GOSS) Is Up 17.7% After Seralutinib Gains Key FDA Support and Clinical Progress - sg.finance.yahoo.com
Gossamer Bio's (GOSS) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Using Bollinger Bands to evaluate Gossamer Bio Inc.Rate Hike & High Accuracy Buy Signal Tips - newser.com
Gossamer Bio, Inc. $GOSS Shares Sold by Siren L.L.C. - MarketBeat
How to build a dashboard for Gossamer Bio Inc. stockMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives $8.50 Average Price Target from Brokerages - Defense World
RSI Crosses Above 30 for Gossamer Bio Inc. — Reversal in SightEarnings Recap Summary & Reliable Price Action Trade Plans - Newser
Can swing trading help recover from Gossamer Bio Inc. lossesPortfolio Value Report & Low Drawdown Trading Strategies - Newser
Gossamer Bio (NASDAQ:GOSS) Shares Gap UpTime to Buy? - MarketBeat
Gossamer Bio Sees Unusually High Options Volume (NASDAQ:GOSS) - MarketBeat
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives $8.50 Average Price Target from Analysts - MarketBeat
What earnings revisions data tells us about Gossamer Bio Inc.2025 Key Lessons & Weekly High Potential Stock Alerts - Newser
Has Gossamer Bio Inc. found a price floorPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser
Tick level data insight on Gossamer Bio Inc. volatilityTrade Volume Summary & Entry Point Strategy Guides - Newser
Using AI based signals to follow Gossamer Bio Inc.Quarterly Profit Report & Weekly High Conviction Ideas - Newser
Chart based analysis of Gossamer Bio Inc. trendsWeekly Stock Recap & Daily Profit Maximizing Tips - Newser
Combining machine learning predictions for Gossamer Bio Inc.Quarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Detecting support and resistance levels for Gossamer Bio Inc.Quarterly Growth Report & Stepwise Trade Signal Guides - Newser
Gossamer Bio (NASDAQ:GOSS) Shares Down 6%Here's Why - MarketBeat
Is Gossamer Bio Inc. forming a bottoming baseQuarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Analyzing recovery setups for Gossamer Bio Inc. investorsStop Loss & Verified Short-Term Trading Plans - Newser
Analyzing drawdowns of Gossamer Bio Inc. with statistical toolsNew Guidance & Smart Money Movement Alerts - Newser
How to recover losses in Gossamer Bio Inc. stockJuly 2025 Macro Moves & Daily Growth Stock Tips - Newser
Should you hold or exit Gossamer Bio Inc. nowEarnings Risk Report & Expert Approved Trade Ideas - Newser
Is Gossamer Bio Inc. building a consolidation basePortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Alyeska Investment Group L.P. Has $4.58 Million Holdings in Gossamer Bio, Inc. $GOSS - MarketBeat
What high frequency data says about Gossamer Bio Inc2025 Key Lessons & Fast Exit and Entry Trade Guides - Newser
Using Python tools to backtest Gossamer Bio Inc. strategiesQuarterly Growth Report & Daily Oversold Stock Bounce Ideas - Newser
How to manage a losing position in Gossamer Bio Inc.Weekly Market Report & Precise Entry and Exit Recommendations - Newser
H.C. Wainwright Asserts Buy Stance on Gossamer Bio Inc. (GOSS) on Pulmonary Arterial Hypertension Drug Prospects - Yahoo Finance
Cantor Fitzgerald reiterates Overweight rating on Gossamer Bio stock - Investing.com
What’s the recovery path for long term holders of Gossamer Bio Inc.2025 Investor Takeaways & Real-Time Chart Breakout Alerts - Newser
Gossamer Bio (NASDAQ:GOSS) Reaches New 52-Week HighHere's Why - MarketBeat
Will breakout in Gossamer Bio Inc. lead to full recoveryJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Gossamer (GOSS) Multibagger Case - Insider Monkey
Can Gossamer Bio Inc. hit a new high this month2025 Top Gainers & Smart Allocation Stock Tips - Newser
Investors Purchase Large Volume of Gossamer Bio Call Options (NASDAQ:GOSS) - Defense World
Price momentum metrics for Gossamer Bio Inc. explained2025 Trading Volume Trends & Growth-Oriented Investment Plans - Newser
Sector ETF performance correlation with Gossamer Bio Inc.2025 Market WrapUp & Accurate Trade Setup Notifications - Newser
Short interest data insights for Gossamer Bio Inc.Weekly Volume Report & Low Risk Entry Point Tips - Newser
Technical analysis overview for Gossamer Bio Inc. stockMarket Performance Report & High Accuracy Trade Alerts - Newser
Gossamer Bio announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Gossamer Bio Shares Rise After UBS Upgrade, PT Increase - MarketScreener
Gossamer Bio’s Bold Progress: Buy or Pass? - StocksToTrade
Gossamer Bio stock rating upgraded by UBS on PAH trial optimism - Investing.com Nigeria
Gossamer Bio stock upgraded at UBS (GOSS:NASDAQ) - Seeking Alpha
What moving averages say about Gossamer Bio Inc.Portfolio Performance Summary & Smart Money Movement Tracker - Newser
UBS Upgrades Gossamer Bio(GOSS.US) to Buy Rating, Raises Target Price to $9 - 富途牛牛
Using data models to predict Gossamer Bio Inc. stock movementTrade Risk Report & Fast Entry High Yield Stock Tips - Newser
How to use a screener to detect Gossamer Bio Inc. breakoutsQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser
How moving averages guide Gossamer Bio Inc. tradingJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):